Novozymes A/S NVZMY · Stock Open Novozymes A/S in new tab
Analyst price targets
Recent rating changes, newest first
Novozymes A/S Analysis (NVZMY)
Is Novozymes A/S a good investment? Novozymes A/S (NVZMY) is currently trading at 68.65 USD. Market analysts have a consensus price target of 73.50 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 43.62. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Novozymes A/S is expected to release its next earnings report on Nov. 5, 2026. The market consensus estimate for Forward EPS is 2.66.
For income investors, Novozymes A/S pays a dividend yield of 1.44%. With a payout ratio of 64%, the dividend appears sustainable.
Investor FAQ
Does Novozymes A/S pay a dividend?
Yes, it pays an annual dividend of 0.88 USD (1.44% yield).
What asset class is Novozymes A/S?
Novozymes A/S is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of 1.59.
Company Profile
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel. In addition, it provides dishwashing, home cleaning, laundry, medical, and industrial and institutional cleaning services; gastrointestinal, immune, mental, women's, children's cardiometabolic, and oral human health solutions. Further, the company offers corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; silage, diary and beef cattle, poultry, swine, aquaculture solutions; pet care solutions; leather and textiles solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions; and distilling, oils and fats, sustainable plastic solutions. Additionally, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S is headquartered in Lyngby, Denmark.
| Year | Total Dividends |
|---|---|
| ▸2027 |
0.75 USD
|
| Sept. 16, 2027 (estimated) | 0.3670 |
| April 12, 2027 (estimated) | 0.3853 |
| ▸2026 |
1.14 USD
|
| Sept. 16, 2026 | 0.3670 |
| April 10, 2026 | 0.1005 |
| April 10, 2026 | 0.6700 |
| ▸2025 |
0.96 USD
|
| Sept. 11, 2025 | 0.3504 |
| April 23, 2025 | 0.6140 |
| ▸2024 |
0.59 USD
|
| Sept. 18, 2024 | 0.2980 |
| May 20, 2024 | 0.2890 |
| ▸2023 |
1.47 USD
|
| Nov. 1, 2023 | 0.5950 |
| March 22, 2023 | 0.8770 |
| ▸2022 |
0.85 USD
|
| April 5, 2022 | 0.8450 |
| ▸2021 |
0.85 USD
|
| March 31, 2021 | 0.8490 |
| ▸2020 |
0.78 USD
|
| March 17, 2020 | 0.7770 |
| ▸2019 |
0.76 USD
|
| March 19, 2019 | 0.7590 |
| ▸2018 |
0.74 USD
|
| April 2, 2018 | 0.7410 |
| ▸2017 |
0.57 USD
|
| March 14, 2017 | 0.5730 |
| ▸2016 |
0.51 USD
|
| March 15, 2016 | 0.5100 |
| ▸2015 |
0.45 USD
|
| March 17, 2015 | 0.4490 |
| ▸2014 |
0.46 USD
|
| March 19, 2014 | 0.4600 |
| ▸2013 |
0.39 USD
|
| March 21, 2013 | 0.3940 |
| ▸2012 |
0.34 USD
|
| March 21, 2012 | 0.3380 |
| ▸2011 |
1.49 USD
|
| March 18, 2011 | 1.4869 |
| ▸2010 |
1.05 USD
|
| March 24, 2010 | 1.0483 |
| ▸2009 |
0.89 USD
|
| March 25, 2009 | 0.8895 |
| ▸2008 |
1.03 USD
|
| March 21, 2008 | 1.0288 |
| ▸2007 |
0.80 USD
|
| March 26, 2007 | 0.7970 |
| ▸2006 |
0.64 USD
|
| March 17, 2006 | 0.6372 |
| ▸2005 |
0.61 USD
|
| April 1, 2005 | 0.6100 |
| ▸2004 |
0.52 USD
|
| April 2, 2004 | 0.5180 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Novozymes A/S | Sep 16, 2026 | Paid | 0.367 USD |
| Novozymes A/S | Apr 10, 2026 | Paid | 0.1005 USD |
| Novozymes A/S | Apr 10, 2026 | Paid | 0.67 USD |
| Split Date | Split Ratio to 1 |
|---|---|
| Dec. 9, 2011 | 5:1 |
Community Discussion